生命科学资讯
生物技术与制药领域的最新动态
Renal PIEZO2 is an essential regulator of renin
A fin-loop-like structure in GPX4 underlies neuroprotection from ferroptosis
Chutes & Ladders—Yet another CDER leadership shake-up
Praxis claims efficacy success in phase 2 seizure trial, setting up approval talks with FDA
Cancer blood test developer Freenome to go public in $330M SPAC deal
Biopharma sentiment hit a turning point in October
OTR Therapeutics gets $100M from Pfizer Ventures, others to build asset portfolio
Hemophilia gene therapies are struggling on the market, even as innovation soars
Praxis soars higher; Bristol Myers’ CAR-T therapy wins broader use
市盈率概览：赛默飞世尔科技 - Benzinga
Price Over Earnings Overview: Thermo Fisher Scientific - Benzinga
Laigo raises €11.5M seed money for targeted protein degradation
FDA conflicts of interest extend beyond adcomm experts
New FGFR3 inhibitors disclosed in Onco3r Therapeutics patent
Synnovation Therapeutics discovers new NRF2 inhibitors
Holiday notice
Knuff & Co LLC出售3,559股赛默飞世尔科技公司$TMO股份 - MarketBeat
Knuff & Co LLC Sells 3,559 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Illumina (NASDAQ:ILMN) Upgraded at Zacks Research - MarketBeat
German court stops Merck from selling subcutaneous Keytruda in patent battle with Halozyme
辉瑞风投支持中国生物科技公司1亿美元A轮融资，以提升研发中心能力。
Pfizer Ventures gets behind Chinese biotech's $100M series A to boost R&D hub's capability